Cargando…

Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module

BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Susana, Crespo, Carla, Canavarro, M. Cristina, Fernandes, Ananda, Batalha, Luís, de Campos, Diana, Pinto, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752803/
https://www.ncbi.nlm.nih.gov/pubmed/26872726
http://dx.doi.org/10.1186/s12955-016-0421-y
_version_ 1782415794545623040
author Santos, Susana
Crespo, Carla
Canavarro, M. Cristina
Fernandes, Ananda
Batalha, Luís
de Campos, Diana
Pinto, Armando
author_facet Santos, Susana
Crespo, Carla
Canavarro, M. Cristina
Fernandes, Ananda
Batalha, Luís
de Campos, Diana
Pinto, Armando
author_sort Santos, Susana
collection PubMed
description BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in children and adolescents with cancer. METHODS: The participants, 332 children/adolescents diagnosed with cancer (8–18 years old), completed measures to assess HRQoL (PedsQL™ 3.0 Cancer Module and DISABKIDS Chronic Generic Measure; DCGM-12) and anxiety (Revised Children’s Manifest Anxiety Scale - second edition; RCMAS-2). A subsample (n = 52) completed the PedsQL™ 3.0 Cancer Module a second time following one-week. The pediatric oncologists completed the Intensity of Treatment Rating Scale 3.0 (ITR 3.0). RESULTS: For the whole sample, the PedsQL™ 3.0 Cancer Module demonstrated good item discrimination (rs = .30 to .54). The confirmatory factor analysis testing the presence of eight first-order factors loading significantly in a second-order factor revealed an acceptable fit (CFI = .91; RMSEA = .05). The correlation of PedsQL™ 3.0 Cancer Module with DCGM-12 (rs = .17 to .58), and with RCMAS-2 (rs = −.16 to–.51) attested convergent validity. This inventory demonstrated minimally acceptable to very good internal consistency (αs = .65 to .87) and temporal stability (ICCs = .61 to .81). CONCLUSIONS: These findings demonstrate that the European Portuguese self-report version of the PedsQL™ 3.0 Cancer Module is a valid and reliable instrument for assessing HRQoL in pediatric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0421-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4752803
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47528032016-02-14 Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module Santos, Susana Crespo, Carla Canavarro, M. Cristina Fernandes, Ananda Batalha, Luís de Campos, Diana Pinto, Armando Health Qual Life Outcomes Research BACKGROUND: Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in children and adolescents with cancer. METHODS: The participants, 332 children/adolescents diagnosed with cancer (8–18 years old), completed measures to assess HRQoL (PedsQL™ 3.0 Cancer Module and DISABKIDS Chronic Generic Measure; DCGM-12) and anxiety (Revised Children’s Manifest Anxiety Scale - second edition; RCMAS-2). A subsample (n = 52) completed the PedsQL™ 3.0 Cancer Module a second time following one-week. The pediatric oncologists completed the Intensity of Treatment Rating Scale 3.0 (ITR 3.0). RESULTS: For the whole sample, the PedsQL™ 3.0 Cancer Module demonstrated good item discrimination (rs = .30 to .54). The confirmatory factor analysis testing the presence of eight first-order factors loading significantly in a second-order factor revealed an acceptable fit (CFI = .91; RMSEA = .05). The correlation of PedsQL™ 3.0 Cancer Module with DCGM-12 (rs = .17 to .58), and with RCMAS-2 (rs = −.16 to–.51) attested convergent validity. This inventory demonstrated minimally acceptable to very good internal consistency (αs = .65 to .87) and temporal stability (ICCs = .61 to .81). CONCLUSIONS: These findings demonstrate that the European Portuguese self-report version of the PedsQL™ 3.0 Cancer Module is a valid and reliable instrument for assessing HRQoL in pediatric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0421-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-13 /pmc/articles/PMC4752803/ /pubmed/26872726 http://dx.doi.org/10.1186/s12955-016-0421-y Text en © Santos et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Santos, Susana
Crespo, Carla
Canavarro, M. Cristina
Fernandes, Ananda
Batalha, Luís
de Campos, Diana
Pinto, Armando
Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title_full Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title_fullStr Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title_full_unstemmed Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title_short Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module
title_sort psychometric study of the european portuguese version of the pedsql 3.0 cancer module
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752803/
https://www.ncbi.nlm.nih.gov/pubmed/26872726
http://dx.doi.org/10.1186/s12955-016-0421-y
work_keys_str_mv AT santossusana psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT crespocarla psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT canavarromcristina psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT fernandesananda psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT batalhaluis psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT decamposdiana psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule
AT pintoarmando psychometricstudyoftheeuropeanportugueseversionofthepedsql30cancermodule